BridgeMD
New treatment option for Indication for CSF Dynamic Testing
Official title Investigation of a New Window Into Intracranial Pressure: Venous Occlusion Pressure of the Isolated Periorbital Vein
ClinicalTrials.gov ID: NCT07053631
What this study is testing
- What it's testing
- Elevated intracranial pressure (ICP) occurs when pressure inside the skull rises above normal levels, potentially leading to brain damage or herniation. Monitoring ICP is critical for managing conditions like brain tumors, traumatic brain injury, and stroke.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 95
You may be able to join if
- Medical indication to perform routine craniospinal CSF dynamic testing according to standard operative procedures
- Aged 18-95
- Willing and able to provide valid signed informed consent
You likely can't join if
- Patients with any known ongoing, or history of, abnormal CSF communication
- Patients with any kind of prior intervention for CSF diversion
- Patients with acute brain damage within the preceding 6 months
- Patients with transdural surgery within the preceding 6 months
- Head wounds or hematoma that could hinder access to measurement site
- Any known pathological condition linked to the orbital socket influencing venous outflow
The study team makes the final eligibility decision.
Where it's taking place
- Freiburg im Breisgau, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 95 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Freiburg im Breisgau, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.